Centro Médico Saavedra
Somos un centro médico de investigacion a la vanguardia de la medicina. Contamos con más de 50 estudios clínicos realizados en distintas áreas clínicas.Av. Ruiz Huidobro 4693, C1430 Cdad. Autónoma de Buenos Aires, Argentina
Select an option
I am a doctor
I am a sponsor
Specializations
Cardiologia
Diabetes y Obesidad
Higado Graso
Neumonologia
Infectologia
Ginecologia
Nefrologia
Our team
Medical staff
Sub InvestigadoraYasmin Tenaglia
Martin Horacio Koretzky
María Eugenia Franchi
Alberto Americo Cristino
Gabriel Aballay Soteras
Juan Cruz Maguire
María Belén Umina
Agustín Maguire
Rodolfo Recoaro
Gustavo Gabriel Castiello
María de la Paz Surraco
Open studies
Cirrhosis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - Boehringer IngelheimSee more
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis - AFFIRM - Gilead SciencesSee more
Fatty liver/nash
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.See more
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - ENLIGHTEN-Fibrosis - 89bio, Inc.See more
Steatohepatitis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH - ENLIGHTEN-Cirrhosis - 89bio, Inc.See more
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - ENLIGHTEN-Fibrosis - 89bio, Inc.See more
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - Boehringer IngelheimSee more
Cholangitis
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis - VANTAGE - Mirum Pharmaceuticals, Inc.See more
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis - AFFIRM - Gilead SciencesSee more
Fatty Liver
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.See more
Heart failure
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer IngelheimSee more
